We are live on ! Find out more
GEVA

SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA

Delisted

GEVA was delisted on the 22nd of June, 2015.

Back to rankings

89 hedge funds and large institutions have $1.09B invested in SYNAGEVA BIOPHARMA CORP COM STK (DE) in 2013 Q2 according to their latest regulatory filings, with 89 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $597K

Holders
89
Holders Change
+89
Holders Change %
–
% of All Funds
2.9%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
89
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
$597K
Net Calls
-$597K
Net Calls Change
-$597K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
JP Morgan Chase
51
JP Morgan Chase
New York
$756K +$820K +17,999 New
MAA
52
Managed Account Advisors
New Jersey
$756K +$821K +18,007 New
MOACM
53
Mutual of America Capital Management
New York
$742K +$805K +17,661 New
HCM
54
Harvey Capital Management
Florida
$730K +$793K +17,400 New
American Century Companies
55
American Century Companies
Missouri
$729K +$773K +16,970 New
RhumbLine Advisers
56
RhumbLine Advisers
Massachusetts
$651K +$706K +15,490 New
ACH
57
ArrowMark Colorado Holdings
Colorado
$651K +$706K +15,500 New
Susquehanna International Group
58
Susquehanna International Group
Pennsylvania
$644K +$698K +15,325 New
NTCOC
59
Northern Trust Company of Connecticut
Connecticut
$641K +$696K +15,270 New
DekaBank Deutsche Girozentrale
60
DekaBank Deutsche Girozentrale
Germany
$601K +$638K +14,000 New
Manulife (Manufacturers Life Insurance)
61
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$584K +$634K +13,902 New
MLICM
62
Metropolitan Life Insurance Company (MetLife)
New York
$582K +$632K +13,859 New
Swiss National Bank
63
Swiss National Bank
Switzerland
$580K +$629K +13,800 New
Prudential Financial
64
Prudential Financial
New Jersey
$551K +$598K +13,120 New
ProShare Advisors
65
ProShare Advisors
Maryland
$526K +$571K +12,524 New
Bank of America
66
Bank of America
North Carolina
$481K +$522K +11,463 New
State Board of Administration of Florida Retirement System
67
State Board of Administration of Florida Retirement System
Florida
$473K +$513K +11,258 New
AQR Capital Management
68
AQR Capital Management
Connecticut
$462K +$501K +11,000 New
VOYA Investment Management
69
VOYA Investment Management
Georgia
$444K +$481K +10,563 New
Jane Street
70
Jane Street
New York
$417K +$453K +9,940 New
DL
71
Delta Lloyd
Netherlands
$413K +$448K +9,835 New
AIG
72
American International Group
New York
$326K +$354K +7,765 New
NCCM
73
Nine Chapters Capital Management
New Jersey
$269K +$292K +6,400 New
BNP Paribas Financial Markets
74
BNP Paribas Financial Markets
France
$267K +$290K +6,365 New
Principal Financial Group
75
Principal Financial Group
Iowa
$259K +$281K +6,157 New
1 2
3
4

GEVA Hedge Fund Activity: Q2 2013 in Review

89 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) for Q2 2013, worth a combined $1.09B.

Buyers outnumbered sellers: 89 funds opened new GEVA positions and 0 closed out — a net gain of 89 holders — while 0 added to existing stakes and 0 trimmed.

  • 89 institutional investors held SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $1.09B of SYNAGEVA BIOPHARMA CORP COM STK (DE) stock for Q2 2013.
  • 89 funds opened new SYNAGEVA BIOPHARMA CORP COM STK (DE) positions in Q2 2013 and 0 closed out, a net change of +89 holders.

Based on aggregated 13F filings for Q2 2013.